- Home
- NVCR vs ETV Comparison
NVCR vs ETV Comparison
Compare NVCR & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCR | ETV |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCR | ETV |
|---|---|---|
| Price | $13.55 | $14.35 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $26.42 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 252.5K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.75% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $642,269,000.00 | N/A |
| Revenue This Year | $9.68 | N/A |
| Revenue Next Year | $6.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.17 | N/A |
| 52 Week Low | $10.70 | $11.05 |
| 52 Week High | $27.47 | $13.50 |
Technical Indicators
Market Signals| Indicator | NVCR | ETV |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | 47.47 |
| Support Level | $12.80 | $14.13 |
| Resistance Level | $14.07 | $14.64 |
| Average True Range (ATR) | 0.66 | 0.14 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 35.52 | 43.14 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.